MyMichigan Health will take a closer look at colorectal cancer during the annual Elsa U. Pardee Foundation Memorial Cancer ...

A clinical explainer outlines bowel and urinary changes that warrant prompt medical evaluation due to potential links with ...

Brenus Pharma announced that new first‑in‑human data will be presented at the AACR Annual Meeting 2026 (April 17–22, San ...

Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer death, yet one ...

AdvisureIQ today announced a strategic Value Added Reseller (VAR) partnership with PlanGuru to expand market reach, accelerate platform adoption, and integrate its financial planning and analysis ...

Good morning, and welcome to Johnson & Johnson's First Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded. [Operator Instructions] I will now turn the call over ...

Biomarkers are revolutionizing oncology drug development, driving modern precision medicine approaches, targeted clinical trial recruitment strategies, and critical decision-making.

Background: Survivors of cancer in adolescence and young adulthood are at increased risk for subsequent primary neoplasms, but studies using Canadian data are limited. We sought to quantify the risk ...

Gastrointestinal (GI) cancers — encompassing colorectal, gastric, pancreatic, hepatocellular, and oesophageal malignancies, among others — remain a leading ...

The intestinal immune system plays a pivotal role in maintaining mucosal homeostasis, acting as the interface between environmental stimuli, host epithelial ...

No more clugged drains ...